A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-03)

Manhattan Behavioral Medicine, New York

Fieve Clinical Research, New York

SPRI Clinical Trials, Inc, Brooklyn

Dr. Cherian Verghese, Norristown

Sheppard Pratt Health System, Baltimore

Department of Psychiatry and Neurobehavioral Sciences, University of Virginia, Charlottesville

Psychiatric Alliance of the Blue Ridge, Inc., Charlottesville

New Hope Clinical Research Inc., Charlotte

Northwest Behavioral Research Center, Marietta

Combined Research Orlando Phase I-IV, Orlando

Research Centers of America, Hollywood

Innova Clinical Trials Inc., Miami

Olympian Clinical Research, Tampa

The University of South Florida Board of Trustees, A public Body Corporate, for University of South Florida, Tampa

Gulfcoast Clinical Research Center, Fort Myers

Harmonex Neuroscience Research, Dothan

Research Strategies of Memphis, LLC, Memphis

AMR - Baber Research, Inc., Naperville

St. Charles Psychiatric Associates - Midwest Research Group, Saint Charles

Psychiatric Care and Research Center, O'Fallon

Psychiatric Associates, Overland Park

Alivation Research, Lincoln

Louisiana Clinical Research, Shreveport

North Texas Clinical Trials, Fort Worth

Grayline Clinical Drug Trials, Wichita Falls

Houston Clinical Trials, LLC, Bellaire

MCB Clinical Research Center, Colorado Springs

Psychiatric and Behavioral Solutions, Salt Lake City

NoesisPharma, Phoenix

Albuquerque Neuroscience, Inc, Albuquerque

Asclepes Research Centers, Panorama City

Artemis Institute for Clinical Research, San Marcos

Sun Valley Research Center, Imperial

Irvine Center for Clinical Research, Inc, Irvine

NRC Research Institute, Orange

University of Massachusetts Medical School, Worcester

Healthy Perspectives - Innovative Mental Health Services. PLLC, Nashua

Hassman Research Institute, LLC, Berlin

Global Medical Institute, LLC, Princeton

Bio Behavioral Health, Toms River